Biologic differences between noninvasive papillary urothelial neoplasms of low malignant potential and low-grade (grade 1) papillary carcinomas of the bladder

American Journal of Surgical Pathology

Volumn 25, Issue 12, 2001, Pages 1528-1533

  Pich, Achille ^a,c   Chiusa, Luigi ^a   Formiconi, Andrea ^b   Galliano, Diego ^a   Bortolin, Paola ^a   Navone, Roberto ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

1998 WHO ISUP classification; 1999 WHO classification; Oncogene expression; Proliferative activity; Urothelial neoplasias

Indexed keywords

ONCOPROTEIN; PROTEIN BCL 2; PROTEIN P53;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; BLADDER TUMOR; CANCER CLASSIFICATION; CANCER GRADING; CANCER RECURRENCE; CELL PROLIFERATION; DIFFERENTIAL DIAGNOSIS; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MITOSIS INDEX; ONCOGENE; PAPILLARY CARCINOMA; SCORING SYSTEM; TRANSURETHRAL RESECTION; UROGENITAL TRACT TUMOR;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NUCLEAR; CARCINOMA, PAPILLARY; CARCINOMA, TRANSITIONAL CELL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTOR, ERBB-2; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 0035185617     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-200112000-00009     Document Type: Article

References (42)

1. Variable Bcl-2 phenotype in benign and malignant lesions of urothelium
2. Urothelial papilloma of the bladder: Clinical and biological implications
3. Papillary urothelial neo-plasms of low malignant potential: Clinical and biologic implication
4. Expression patterns of erbB receptor family in normal urothelium and transitional cell carcinoma: An immunohistochemical study
5. Cooperative effects of p53 and pRB alterations in primary superficial bladder tumors
6. The World Health Organization/International Society of Urological Pathology Consensus Classification of urothelial (transitional cell) neoplasms of the urinary bladder
7. Proliferative pattern of exophytic and superficially invasive and noninvasive low-grade urothelial carcinomas
8. Assessment of basal cell status and pro-liferative patterns in flat and papillary urothelial lesions: A contribution to the new WHO classification of urothelial tumors of the urinary bladder
9. Stage progression in Ta papillary urothelial tumors: Relationship to grade, immunohistochemical expression of tumor markers, mitotic frequency and DNA ploidy
10. Recurrence and progression in low grade papillary urothelial tumors
11. Non parametric estimation for incomplete observations
12. Incidence of apoptosis, cell proliferation and bcl-2 expression in transitional cell carcinoma of the bladder: Association with tumor progression
13. The role of p53, MDM2 and c-erb B-2 oncoproteins, epidermal growth factor receptor and proliferation markers in the prognosis of urinary bladder cancer
14. Investigation of p53, c-erbB-2, PCNA immunoreactivity, DNA content, AgNOR and apoptosis in bladder carcinoma as prognostic parameters
15. Biology of disease. Urinary bladder cancer: Mechanisms of development and progression
16. Expression of c-erbB-2 protein in normal and neoplastic urothelium: Lack of adverse prognostic effect in human urinary bladder cancer
17. Expression of c-erbB-2 oncoprotein in transitional cell bladder cancer
18. Expression of the apoptosis suppressing bcl-2 protein in transitional cell bladder tumors
19. Grading of superficial bladder cancer by quantitative mitotic frequency analysis
20. Over-expression of p53 nuclear oncoprotein in transitional-cell bladder cancer and its prognostic value
21. Immunoreactivity of bcl-2, p53 and EGFr is associated with tumor stage, grade and cell proliferation in superficial bladder cancer: Finnbladder III group
22. Prognostic value of amplification of c-erb-B2 in bladder carcinoma
23. Cell cycling in bladder carcinoma determined by monoclonal antibody Ki67
24. Histological typing of urinary bladder tumors
25. Prognostic factors in bladder carcinoma: Histologic parameters and expression of a cell cycle-related nuclear antigen (Ki-67)
26. The prevalence of bcl-2, p53 and Ki-67 immunoreactivity in transitional cell bladder carcinomas and their clinicopathologic correlates
27. The relationship between c-erbB-2 expression, S-phase fraction and prognosis in breast cancer
28. MIB-1 as a proliferative marker in transitional cell carcinoma of the bladder: Clinical significance and comparison with other prognostic factors
29. Detection of c-erbB-2 amplification in transitional cell bladder carcinoma using competitive PCR technique
30. Comparative analysis of MIB1 and p53 expression in human bladder tumors and their correlation with cancer progression
31. Prognostic value of the Proliferative Index determined by Ki-67 immunostaining in superficial bladder tumors
32. Cell proliferation indices, morphometry and DNA flow cytometry provide objective criteria for distinguishing low and high grade bladder carcinomas
33. The prognostic value of p53 nuclear overexpression and MIB-1 as a proliferative marker in transitional cell carcinoma of the bladder
34. Immunohistochemical analysis of bcl-2 expression in transitional cell carcinoma of the bladder
35. p53 immuno-histochemistry in transitional cell carcinoma and dysplasia of the urinary bladder correlates with disease progression
36. The expression of p53 and bcl-2 in superficial bladder transitional cell carcinoma and its role in outcome of postoperative intravesical chemotherapy
37. The role of bcl-2, p53, and Ki-67 index in predicting tumor recurrence for low grade superficial transitional cell bladder carcinoma
38. Correlation between the expression of oncogenes ras and c-erbB-2 and the biologic behavior of the bladder tumors
39. Expression of p53 product in Chinese human bladder carcinoma